Search research articles
Contact Us
Filters
Showing results (691-700 of 788) with videos related to
Page
of 79
Sort By:
Sports Medicine - Open
|
June 10, 2026
Project FURTHER: A Physiological, Biomechanical, and Psychosocial Profile of an All-Female 6-Day Ultramarathon Race
Hannah G Caldwell, Trent Stellingwerff, Robert J Gathercole, et al.
Mhealth
|
February 26, 2021
The usefulness of the Electronic Patient Visit Assessment (ePVA)<sup>©</sup> as a clinical support tool for real-time interventions in head and neck cancer
Janet H Van Cleave, Mei R Fu, Antonia V Bennett, et al.
JCO Clinical Cancer Informatics
|
October 28, 2020
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial
Ethan Basch, Angela M Stover, Deborah Schrag, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 6, 2024
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
Minji K Lee, Sandra A Mitchell, Ethan Basch, et al.
JCO Oncology Practice
|
August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure
Yashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
Clinical Trials (London, England)
|
December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch, Claus Becker, Lauren J Rogak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
Ethan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
European Urology
|
December 12, 2018
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
Ethan M Basch, Mark Scholz, Johann S de Bono, et al.
European Urology
|
March 18, 2014
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort
Ethan Basch, Karen A Autio, Matthew R Smith, et al.
JAMA Oncology
|
December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
Ann H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Page
of 79
Search research articles
Search
Showing results (691-700 of 788) with videos related to
Sort By:
Page
of 79
Sports Medicine - Open
|
June 10, 2026
Project FURTHER: A Physiological, Biomechanical, and Psychosocial Profile of an All-Female 6-Day Ultramarathon Race
Hannah G Caldwell, Trent Stellingwerff, Robert J Gathercole, et al.
Mhealth
|
February 26, 2021
The usefulness of the Electronic Patient Visit Assessment (ePVA)<sup>©</sup> as a clinical support tool for real-time interventions in head and neck cancer
Janet H Van Cleave, Mei R Fu, Antonia V Bennett, et al.
JCO Clinical Cancer Informatics
|
October 28, 2020
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial
Ethan Basch, Angela M Stover, Deborah Schrag, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 6, 2024
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
Minji K Lee, Sandra A Mitchell, Ethan Basch, et al.
JCO Oncology Practice
|
August 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure
Yashasvini Sampathkumar, Corrine I Voils, Gina L Mazza, et al.
Clinical Trials (London, England)
|
December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch, Claus Becker, Lauren J Rogak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
Ethan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
European Urology
|
December 12, 2018
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
Ethan M Basch, Mark Scholz, Johann S de Bono, et al.
European Urology
|
March 18, 2014
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort
Ethan Basch, Karen A Autio, Matthew R Smith, et al.
JAMA Oncology
|
December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
Ann H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Page
of 79